Blog - Page 434 of 5677 - QualityStocks

TuesdaySep 03, 2024 11:15 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Management to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company today announced that its management will present at the H.C. Wainwright 26th Annual Global Investment Conference and host 1x1 investor meetings. The virtual presentation is scheduled for September 9, 2024, at 7 a.m. EST. To view the webcast of the presentation, visit https://ibn.fm/6ncBJ To view the full press release, visit https://ibn.fm/Qkp6L About Clene Inc. Clene…

TuesdaySep 03, 2024 11:15 am

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Ideally Positioned to Support Federal Efforts to Expand, Develop Critical Minerals Mining

The nation’s overreliance on foreign sources, adversarial nations for critical minerals and materials poses national and economic security threats, says report If establishing critical mineral independence is truly a western goal, it is essential that North American nickel mines be discovered, developed Fathom Nickel is focused on supplying critical minerals to support the new green economy Early in the Biden-Harris Administration, a first-of-its-kind report was released providing a supply chain assessment for critical minerals that found the nation’s “overreliance on foreign sources and adversarial nations for critical minerals and materials posed national and economic security threats” (https://ibn.fm/QOB8b). The report provided several suggestions…

TuesdaySep 03, 2024 10:30 am

Torr Metals Inc. (TSX.V: TMET) Bolsters Board with Distinguished Industry Leader

Torr Metals has strengthened its board by appointing Gordon Maxwell, a highly distinguished geologist who brings nearly four decades of experience from major industry players like Noranda, Xstrata, and Glencore Maxwell's expertise in exploration and sustainable mining, along with his recognized contributions to Indigenous communities, aligns well with Torr's values and project goals The addition of Maxwell mirrors successful strategies by other mining companies that have enhanced corporate value by assembling diverse, experienced boards, positioning Torr Metals for future growth and value creation Torr Metals (TSX.V: TMET) has made a strategic move to strengthen its board of directors with the…

TuesdaySep 03, 2024 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Extends Quantum AI Product Roadmap, Quantum Cloud Service Enhancements Featured in Syndicated Broadcast

The extended product roadmap is part of the company’s efforts to strengthen the connection between quantum optimization, AI and Machine Learning (“ML”), in order to bring new Quantum Artificial Intelligence (“AI”) solutions to market D-Wave’s annealing quantum computing solutions could play a key role in improving AI/ML with more efficient model training, reduced energy consumption, and faster time-to-solution The company’s Quantum AI solutions could be transformative, bringing a powerful new set of new computing tools for generative AI D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first commercial provider of quantum computers, was…

TuesdaySep 03, 2024 9:00 am

11th Annual ROTH Solar & Storage Symposium Invites Public and Private Solar and Storage Companies, Plus Investors

The 11th Annual Solar & Storage Symposium at RE+ by Roth Capital Partners will held September 10-11, 2024, at the Anaheim Convention Center in Anaheim, CA. The symposium represents public and private solar and storage companies spanning the industry ecosystem. Roth Capital Partners has been organizing these symposiums since 2005, with a vision to bring industry personnel on a common forum for interaction, networking, education, and business. The Roth symposium includes presentations, discussions, fireside chats, and small group meetings. The Roth team will conduct 40-minute one-on-one meetings between the investors and management for insights into the workings of each company. Investors can…

FridayAug 30, 2024 2:48 pm

QualityStocksNewsBreaks – MoneyShow Hosts Toronto Politics, Policy and Profits Event Next Month

MoneyShow, a leading producer of financial conferences for affluent investors active traders, and financial advisors, is reporting on the agenda for next month’s The MoneyShow Toronto — Outlook 2024–25 Politics, Policy and Profits Conference. MoneyShow is hosting the event, which is slated for Sept. 13–14, 2024. According to the announcement, MoneyShow conferences are designed to be dynamic industry events that provide participants with world-class educational insights and training in trading and investing domains while also creating highly professional conclaves that offer ideal high-powered networking and knowledge exchange opportunities. Participants at the event, including investors and traders, will attend presentations, panels and…

FridayAug 30, 2024 2:45 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the expansion of the minor cannabinoid market in 2023. “The report, based on data from Headset, the largest industry dataset, explores the growth, competition and consumer trends in ten regulated states, encompassing 85 million of the 158 million residents in areas where recreational cannabis is legal,” reads a recent article. “The report highlights a 5.4% revenue increase in the edible market,…

FridayAug 30, 2024 2:41 pm

QualityStocksNewsBreaks – Upstream Releases New Episode of Upstream Up Close Twitter Series, Offers Insight into Navigating Market Downturns

Upstream, a MERJ Exchange stock market and global trading app, team hosted the 16th episode of its Upstream Up Close series on Twitter (X) Spaces. Upstream noted the release of the episode, explaining that the series features 10–15 minute discussions covering key topics in the world of digital collectibles, Web3 and trading on Upstream. Episode 16 specifically focused on the potential of blockchain technology to revolutionize stock market trading, as well as the benefits blockchain-powered markets can provide during times of market volatility. In addition, the Upstream article called out the valuable insight the episode provided regarding navigating the rapids…

FridayAug 30, 2024 2:38 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases

Clene (NASDAQ: CLNN), a biopharmaceutical company, is at the forefront of transforming the treatment of neurodegenerative disorders like amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). “Clene’s lead agent, CNM-Au8, targets the nicotinamide adenine dinucleotide (‘NAD+’) pathway to restore and protect neurological function. CNM-Au8 works by improving cellular energy production and utilization, which is crucial for maintaining neuronal health. Mitochondrial dysfunction is a common pathway leading to neuronal death in neurodegenerative diseases. By targeting this dysfunction, CNM-Au8 aims to provide neuroprotection and promote remyelination, potentially altering the course of these debilitating conditions,” a recent article reads. “Clene has conducted extensive…

FridayAug 30, 2024 2:15 pm

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Expands Team in Continued Focus to Make Meaningful Impact on Lives of AD, PD Patients

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), recently welcomed four seasoned professionals to its executive team. “Annovis Bio is excited about the new additions and confident that these highly experienced professionals will significantly contribute to the company’s mission of developing transformative therapies for neurodegenerative diseases. The combined expertise of Mark White, Alexander Morin, Hilda Maibach, and Blake Jensen will enhance strategic initiatives, strengthen communications, refine statistical approaches, and ensure the highest standards of quality. The company looks forward to their…

Site Search

Company Search